Skip to content
  • Sunday, 26 July 2026
  • 2:49 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Breakthrough Combination Therapy Offers New Hope for Acute Myelogenous Leukemia Treatment Through Epigenetic Reprogramming
Stem Cell & Regenerative Medicine

Breakthrough Combination Therapy Offers New Hope for Acute Myelogenous Leukemia Treatment Through Epigenetic Reprogramming

Dwi Wanna Apr 18, 2026 0

Acute Myelogenous Leukemia (AML) has long remained one of the most formidable challenges in oncology, characterized by its rapid progression…

Read More
Clinical Diagnostics & Pathology

Rising Therapy-Related Leukemia Rates Signal New Testing Demands for Clinical Labs

Reynand Amr Wu Apr 14, 2026 0

A new population-based study, published in CANCER, a journal of the American Cancer Society, has brought into sharp focus a…

Read More
Stem Cell & Regenerative Medicine

Explosive Growth and Evolutionary Timelines of Chronic Myeloid Leukemia Revealed Through Genomic Mapping

Dwi Wanna Apr 11, 2026 0

A groundbreaking study led by researchers at the Wellcome Sanger Institute has fundamentally altered the scientific understanding of chronic myeloid…

Read More
Stem Cell & Regenerative Medicine

Ludwig Cancer Research Unveils Synergistic Combination Therapy Targeting Differentiation Blockade in Acute Myelogenous Leukemia

Dwi Wanna Apr 11, 2026 0

The landscape of hematological oncology is facing a potential paradigm shift following a landmark study by Ludwig Cancer Research, which…

Read More
Stem Cell & Regenerative Medicine

New Research Unveils the Pre-Diagnostic Timeline and Explosive Growth Rates of Chronic Myeloid Leukemia

Dwi Wanna Apr 4, 2026 0

A groundbreaking study led by researchers at the Wellcome Sanger Institute has fundamentally altered the scientific understanding of how chronic…

Read More
Stem Cell & Regenerative Medicine

Ludwig Cancer Research Study Identifies Novel Combination Therapy to Overcome Differentiation Block in Acute Myelogenous Leukemia

Dwi Wanna Apr 4, 2026 0

The landscape of hematological oncology is facing a potential paradigm shift following a comprehensive study led by Ludwig Cancer Research,…

Read More
Stem Cell & Regenerative Medicine

Rapid Growth and Early Origins of Chronic Myeloid Leukemia Revealed by Genomic Ancestry Study

Dwi Wanna Mar 27, 2026 0

A landmark study led by the Wellcome Sanger Institute has redefined the scientific understanding of chronic myeloid leukemia (CML), uncovering…

Read More
Stem Cell & Regenerative Medicine

Ludwig Cancer Research Unveils Dual-Inhibitor Strategy to Combat Acute Myelogenous Leukemia by Overcoming Cellular Differentiation Blockade

Dwi Wanna Mar 27, 2026 0

The landscape of hematological oncology is facing a potential paradigm shift following a landmark study by Ludwig Cancer Research, which…

Read More
Stem Cell & Regenerative Medicine

New Genomic Research Unveils the Rapid Evolutionary Timeline and Explosive Growth Rates of Chronic Myeloid Leukemia

Dwi Wanna Mar 20, 2026 0

In a landmark study published in the journal Nature, researchers from the Wellcome Sanger Institute and their international collaborators have…

Read More
Stem Cell & Regenerative Medicine

Breakthrough Study Reveals Synergistic Drug Combination to Overcome Differentiation Blockade in Acute Myelogenous Leukemia

Dwi Wanna Mar 19, 2026 0

In a landmark advancement for hematologic oncology, researchers from Ludwig Cancer Research have unveiled a novel therapeutic strategy aimed at…

Read More

Posts pagination

1 … 3 4
Top 5 MCP Servers for High-Performance Agentic DevelopmentLilly’s plans to buy CAR-T firm Kelonia in deal worth up to $7 billion. Can its deal spree avoid Pfizer’s fate?Lilly is now the top pharma company by revenue as Mounjaro (+99%) and Zepbound (+175%) combine for $36.5B in FY2025Ludwig Cancer Research Study Identifies Novel Combination Therapy to Overcome Differentiation Block in Acute Myelogenous Leukemia
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ